Latest Industry Insights

Single-cell technologies are transforming our knowledge of human health and disease. In this article, Gary Kruppa outlines the latest advances in single-cell proteomics.

In this instalment of Science Futures, Rajannya discusses the real-world applications of her research and explains how technologies have steered her work.

In this instalment of Science Futures, we hear from Max Lennart Feuerstein. Max tells us more about his research and how it could drive technical enhancements of data acquisition workflows

Here we highlight some of the innovations featured at the 69^th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics.

While many of us are still attending events remotely, ASMS 2021 has been in full swing this year with in-person talks and events. To give you a taste of the topics proving popular this year, Technology Networks has produced a round up to highlight a selection of key themes and innovations.

There is an inherent link between academia and industry that rarely gets the acknowledgement it deserves. Hear from a roundtable of PhD students on the impact that the collaborative relationship between academia and industry has on their work and the role that technology plays in the “Science Futures” initiative.

The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients. Dxcover has developed a new spectroscopic liquid biopsy approach that is able to identify brain tumors as small as 0.2 cm³ from a blood sample in as little as fifteen minutes.

To find out more about HPIMS, Technology Networks spoke with Dr. Ching Wu, founder and chief executive officer at Excellims and a pioneer of HPIMS. In this interview, Dr. Wu talks about the advantages that the technique can offer in applications ranging from pharma PAT to clinical diagnostics, and discusses how Excellims is increasing accessibility to the technology.

In this interview, Kevin Wyndham, senior director of research and development at Waters, highlights how a new LC-MS method could be used to support research both during and beyond the COVID-19 pandemic.

Technology Networks spoke with Dr. Caroline Loew, CEO of Glympse Bio to learn more about the use of activity-based biosensors in fibrotic disease.